PRESS RELEASE published on 06/04/2024 at 19:30, 2 years 2 months ago Crossject announces highly successful closing of its €8 million rights offering Crossject successfully closes €8 million rights offering, securing funding for ZEPIZURE® development and FDA approval. Gemmes Venture remains a key supporter FDA Approval Rights Offering Crossject ZEPIZURE® Gemmes Venture
BRIEF published on 05/30/2024 at 10:35, 2 years 2 months ago Crossject: Publication of Clinical Data on ZEPIZURE® Crossject ZEPIZURE® Neurology And Therapy Midazolam Needle-free Injection
PRESS RELEASE published on 05/30/2024 at 10:30, 2 years 2 months ago Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy Crossject announces publication of clinical data on ZEPIZURE in Neurology and Therapy, highlighting bioequivalence versus Dormicum, early onset, and low variability Clinical Data Crossject Neurology And Therapy ZEPIZURE Needle-free Auto-injector
Published on 08/05/2026 at 02:10, 3 hours 51 minutes ago Kleen Hy-Dro-Gen Inc. Is Pleased to Announce Dual ISO 9001:2015 and TSSA Certifications, Bolstering Operational Quality and Technical Safety Governance
Published on 08/04/2026 at 22:30, 7 hours 31 minutes ago Nextech3D.ai Provides Update on Acquisition of Remaining ARway Shares
Published on 08/04/2026 at 16:25, 13 hours 36 minutes ago ACCESS Newswire to Host Second Quarter Earnings Conference Call on August 11, 2026
Published on 08/04/2026 at 15:00, 15 hours 1 minute ago Infield Minerals Expands Land Position at the Kings Canyon Gold Project in Utah
Published on 08/04/2026 at 22:03, 7 hours 57 minutes ago #FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised
Published on 08/04/2026 at 22:01, 7 hours 59 minutes ago EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance
Published on 08/04/2026 at 20:05, 9 hours 55 minutes ago Hard Rock Cafe and Coca-Cola® Launch Hard Rock Rising Music Competition for Emerging Artists
Published on 08/04/2026 at 19:39, 10 hours 21 minutes ago EQS-Adhoc: Basler AG financial results for the first 6 months of 2026: Strong business performance in the first half of the year; company raises its 2026 forecast once again
Published on 08/04/2026 at 18:32, 11 hours 28 minutes ago Total number of voting rights and shares making up the share capital at July 31, 2026
Published on 08/04/2026 at 17:45, 12 hours 16 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 08/04/2026 at 16:00, 14 hours 1 minute ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 08/04/2026 at 08:15, 21 hours 46 minutes ago Covivio - Conditions of availability of the 2026 Half-year report
